Academic oncologists translating complex research into insight you can use on Monday morning.
Dr. Neil J. Shah is a leading academic medical oncologist whose work in real-world toxicity management is reshaping how clinicians approach next-generation cancer therapies. His research spans treatment-related adverse events, data-driven oncology solutions, and clinical outcomes optimization — contributions that have helped shape practice standards through publications in premier medical journals.
A dedicated educator and mentor, Dr. Shah has guided many trainees to success, fostering the next generation of oncology leaders. His ability to translate complex clinical research into accessible, clinically relevant practice sets him apart in the field.
Through SmartOnc Studio, Dr. Shah delivers expert, multidisciplinary education that equips oncology teams to recognize, prevent, and manage treatment-related toxicities. His patient-centered, evidence-based approach is built around a simple goal: safer care and more time that matters for patients living with cancer.
Dr. Matthew Dallos is an academic oncologist focused on advancing modern cancer treatment. As a clinical and translational researcher, he leads clinical trials in immune and targeted therapies, with a research program centered on the tumor microenvironment and novel immunotherapeutic approaches.
In his clinical practice he cares for men with prostate cancer and works closely with a team of talented physicians, advanced practitioners, nurses, fellows, residents, and students. He has been recognized as an outstanding educator and previously served as a chief resident and chief fellow, and speaks widely on oncology treatment management and novel therapeutics.
Through SmartOnc Studio, Dr. Dallos translates complex therapeutic advances into practical, clinically relevant insights for real-world practice — delving into emerging data, next-generation therapies, and toxicity management pearls to deliver safer care and more time that matters for patients living with cancer.
Dr. Matthew Dallos is an academic oncologist focused on advancing modern cancer treatment. As a clinical and translational researcher, he leads clinical trials in immune and targeted therapies, with a research program centered on the tumor microenvironment and novel immunotherapeutic approaches.
In his clinical practice he cares for men with prostate cancer and works closely with a team of talented physicians, advanced practitioners, nurses, fellows, residents, and students. He has been recognized as an outstanding educator and previously served as a chief resident and chief fellow, and speaks widely on oncology treatment management and novel therapeutics.
Through SmartOnc Studio, Dr. Dallos translates complex therapeutic advances into practical, clinically relevant insights for real-world practice — delving into emerging data, next-generation therapies, and toxicity management pearls to deliver safer care and more time that matters for patients living with cancer.
Collaborative environments designed for real-time problem solving.
SmartOnc Studio is powered by a community of trusted healthcare professionals dedicated to advancing the safe and effective use of next-generation oncology therapies. Join our network at the next Strategy Summit.
